{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:01:23Z","timestamp":1769504483735,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.virs.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T15:56:10Z","timestamp":1716047770000},"page":"490-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice"],"prefix":"10.1016","volume":"39","author":[{"given":"Xiuli","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9391-9707","authenticated-orcid":false,"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4177-6038","authenticated-orcid":false,"given":"Yiming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2024.05.005_bib1","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2017.05.032","article-title":"ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice","volume":"35","author":"Alharbi","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2024.05.005_bib2","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 breakthrough infections in vaccinated health care workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2024.05.005_bib3","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S2666-5247(21)00193-2","article-title":"Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial","volume":"3","author":"Bosaeed","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.virs.2024.05.005_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/imr.13016","article-title":"Memory B cells and plasma cells: the differentiative continuum of humoral immunity","volume":"303","author":"Cancro","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.virs.2024.05.005_bib5","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.vaccine.2017.02.063","article-title":"DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice","volume":"35","author":"Chi","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2024.05.005_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823949","article-title":"Inactivated rabies virus vectored MERS-Coronavirus vaccine induces protective immunity in mice, camels, and alpacas","volume":"13","author":"Chi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2024.05.005_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41541-021-00303-w","article-title":"Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2","volume":"6","author":"Cho","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.virs.2024.05.005_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01176-20","article-title":"Cross-protection against MERS-CoV by prime-boost vaccination using viral spike DNA and protein","volume":"94","author":"Choi","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2024.05.005_bib9","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-020-1083-1","article-title":"Seasonal coronavirus protective immunity is short-lasting","volume":"26","author":"Edridge","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2024.05.005_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(21)01699-8","article-title":"Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)","volume":"398","author":"Flaxman","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2024.05.005_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02260-20","article-title":"COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike protein induce robust T- and B-cell immune responses and full efficacy in mice","volume":"95","author":"Garcia-Arriaza","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2024.05.005_bib12","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/infdis\/jiz137","article-title":"A\u00a0highly immunogenic, protective, and safe adenovirus-based vaccine expressing Middle East respiratory syndrome coronavirus S1-CD40L fusion protein in a transgenic human dipeptidyl peptidase 4 mouse model","volume":"220","author":"Hashem","year":"2019","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.virs.2024.05.005_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.retram.2022.103348","article-title":"Preclinical study of a DNA vaccine targeting SARS-CoV-2","volume":"70","author":"Hayashi","year":"2022","journal-title":"Current Research in Translational Medicine"},{"key":"10.1016\/j.virs.2024.05.005_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4939-2742-5_9","article-title":"The western blot","volume":"1318","author":"Hnasko","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virs.2024.05.005_bib15","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/vaccines10111843","article-title":"Comparing the immunogenicity and protective effects of three MERS-CoV inactivation methods in mice","volume":"10","author":"Kim","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.virs.2024.05.005_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1473-3099(20)30248-6","article-title":"Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial","volume":"20","author":"Koch","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2024.05.005_bib17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","article-title":"A\u00a0single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice","volume":"53","author":"Laczk\u00f3","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2024.05.005_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virs.2024.05.005_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","article-title":"Molecular mechanisms for enhanced DNA vaccine immunogenicity","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virs.2024.05.005_bib20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12929-020-00695-2","article-title":"Coronavirus vaccine development: from SARS and MERS to COVID-19","volume":"27","author":"Li","year":"2020","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.virs.2024.05.005_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41577-020-00460-4","article-title":"Cross-reactive memory T cells and herd immunity to SARS-CoV-2","volume":"20","author":"Lipsitch","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virs.2024.05.005_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12250-013-3303-z","article-title":"Potent T cell responses induced by single DNA vaccine boosted with recombinant vaccinia vaccine","volume":"28","author":"Liu","year":"2013","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virs.2024.05.005_bib23","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1016\/j.vaccine.2012.04.075","article-title":"Broad HIV-1 neutralizing antibody response induced by heterologous gp140\/gp145 DNA prime-vaccinia boost immunization","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2024.05.005_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/QAD.0000000000000595","article-title":"HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection","volume":"29","author":"Liu","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.virs.2024.05.005_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.911164","article-title":"Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate","volume":"13","author":"Mei","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2024.05.005_bib26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1473-3099(19)30266-X","article-title":"Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial","volume":"19","author":"Modjarrad","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2024.05.005_bib27","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","article-title":"Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay","volume":"15","author":"Nie","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.virs.2024.05.005_bib28","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2024.05.005_bib29","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1016\/S2352-3018(19)30262-0","article-title":"Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial","volume":"6","author":"Pantaleo","year":"2019","journal-title":"The Lancet HIV"},{"key":"10.1016\/j.virs.2024.05.005_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.2020.0757","article-title":"Coronavirus infections-more than just the common cold","volume":"323","author":"Paules","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.virs.2024.05.005_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.21775\/cimb.022.129","article-title":"DNA vaccine delivery and improved immunogenicity","volume":"22","author":"Porter","year":"2017","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.virs.2024.05.005_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2021.01.014","article-title":"B\u00a0cell memory: understanding COVID-19","volume":"54","author":"Quast","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2024.05.005_bib33","article-title":"Emergence of the Middle East respiratory syndrome coronavirus","volume":"9","author":"Racaniello","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2024.05.005_bib34","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1080\/22221751.2019.1685912","article-title":"Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein","volume":"8","author":"Rodon","year":"2019","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virs.2024.05.005_bib35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2021.02.001","article-title":"A\u00a0modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs","volume":"54","author":"Routhu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2024.05.005_bib36","article-title":"A\u00a0nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice","volume":"29","author":"Sahu","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.virs.2024.05.005_bib37","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3390\/v13081579","article-title":"Coronavirus pseudotypes for all circulating human coronaviruses for quantification of cross-neutralizing antibody responses","volume":"13","author":"Sampson","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2024.05.005_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jiph.2016.04.008","article-title":"Clinical spectrum of the Middle East\u00a0respiratory syndrome coronavirus (MERS-CoV)","volume":"10","author":"Senga","year":"2017","journal-title":"J\u00a0Infect Public Health"},{"key":"10.1016\/j.virs.2024.05.005_bib39","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/vir.0.81063-0","article-title":"Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor","volume":"86","author":"Sisso\u00ebff","year":"2005","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.virs.2024.05.005_bib40","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","article-title":"Immunogenicity of a DNA vaccine candidate for COVID-19","volume":"11","author":"Smith","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2024.05.005_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02549-23","article-title":"Enhanced immunogenicity elicited by a novel DNA vaccine encoding the SARS-CoV-2 S1 protein fused to the optimized flagellin of Salmonella typhimurium in mice","volume":"11","author":"Song","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.virs.2024.05.005_bib42","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/infdis\/jiac445","article-title":"Safety and immunogenicity of Ad26-vectored HIV vaccine with mosaic immunogens and a novel mosaic envelope protein in HIV-uninfected adults: a phase 1\/2a study","volume":"227","author":"Stieh","year":"2023","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.virs.2024.05.005_bib43","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"Tang","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.virs.2024.05.005_bib44","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"89","author":"Volz","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2024.05.005_bib45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.chom.2014.08.009","article-title":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26","volume":"16","author":"Wang","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virs.2024.05.005_bib47","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.vaccine.2019.04.070","article-title":"Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice","volume":"37","author":"Xie","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2024.05.005_bib48","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41586-022-05513-3","article-title":"Close relatives of MERS-CoV in bats use ACE2 as their functional receptors","volume":"612","author":"Xiong","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2024.05.005_bib49","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X24000737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X24000737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T15:16:59Z","timestamp":1719674219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X24000737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1995820X24000737"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2024.05.005","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}